VetiCell, LLC, has announced that it is launching a proactive stem cell storage program for animals, in which it will collect stem cells from the umbilical cord of horses or from the reproductive tissues of dogs following spay or neuter.
VetiCell is a sister company to AlphaCord, a human cord blood bank, with the two companies having the same owner and staff.
Currently, there are a couple companies operating in the veterinary stem cell market that collect stem cells through invasive methods (adipose or bone marrow). However, VetiCell’s new model is to collect veterinary stem cells without surgery from the umbilical cord of horses or from reproductive tissues after canine spay and neuter. These methods require no additional invasive surgery to collect an animal’s stem cells.
Since 2006, BioInformant has been tracking the human stem cell banking market. Initially, the market was focused on the storage of umbilical cord blood, although it has expanded over the past ten years to include the storage of other types of stem cells, including those present within cord tissue, dental pulp, adipose tissue, and more.
With hundreds of human cord blood banks now competing worldwide, it will be interesting to see whether any of them add equine cord blood banking to their portfolio of human stem cell storage services.
To learn more, read the full press release from VetiCell, LLC, below, released with permission from company representative, Hal Rogness.
VetiCell Launches Veterinary Stem Cell Preservation Program
ATLANTA, March 14, 2016 /PRNewswire-iReach/ — VetiCell, LLC has announced the launch of its proactive stem cell preservation program for horses and dogs. Animal owners can now save the stem cells from a young and healthy animal for potential use in the future.
Even though stem cell therapy is not new, and has been used in thousands of animals with orthopedic disease and injury, its potential is far from fully developed. Regenerative medicine research continues at a rapid pace. In university research centers, stem cells are being studied by veterinarians to treat osteoarthritis, eye diseases, immune-mediated and inflammatory diseases, as well as organ disorders.
Working with veterinarians to collect the samples, dog owners can now preserve the stem cells found in reproductive tissues after a spay or neuter; and horse owners or breeders can preserve the stem cells from the umbilical cord at foaling. “The prevalent method has been to wait until the animal is disabled and then perform an invasive surgery to obtain tissue for the stem cells”, says VetiCell Sales & Marketing Manager, Jeremy Gentry. “Now owners can save cells prior to illness in a noninvasive and much more affordable procedure.”
Two years in development, which included a University Veterinary Medical School study to validate the procurement and laboratory process, VetiCell was conceived to provide a more animal friendly and affordable way to plan for Stem Cell Therapy. “Based on our thirteen years preserving newborn stem cells through our human stem cell company, AlphaCord, we are well positioned and experienced to offer a similar service to the veterinary market”, said Hal Rogness, VP.
For more information, visit VetiCell.com or call 404-315-7008.
Media Contact
Laurielle Robinson, VetiCell, 4043250501, lrobinson@alphacord.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE VetiCell, LLC
Want to be better informed than your competition? Get future stem cell industry updates.
About Us
BioInformant is the first and only market research firm to specialize exclusively in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.